GLOBE LIFE INC. REPORTS FOURTH QUARTER 2023 RESULTS
Net income for the year ended
The results included herein reflect the adoption of ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI).
HIGHLIGHTS:
- Net income as an ROE was 23.2% for the twelve months ended
December 31, 2023 . Net operating income as an ROE excluding accumulated other comprehensive income (AOCI) was 14.7% for the same period. - Net income increased 13% and net operating income increased 6% over the year-ago quarter. For the full year, net income was
$971 million and net operating income surpassed$1.0 billion for the first time in company history. - At the American Income Life Division, life net sales increased 9% and life premium increased 7% over the year-ago quarter. Additionally, the average producing agent count increased 20% over the year-ago quarter.
- At the Liberty National Division, life net sales and health net sales increased over the year-ago quarter by 12% and 9%, respectively. Additionally, life premiums increased 8% and the average producing agent count increased 15% over the year-ago quarter.
- At the Family Heritage Division, health net sales increased 12% and premiums increased 8% over the year-ago quarter.
- Net investment income grew 6% over the year-ago quarter.
- 660,170 shares of
Globe Life Inc. common stock were repurchased during the quarter.
Note: As used in the earnings release, " |
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||||||||||
RESULTS OF OPERATIONS |
|||||||||||
Net operating income, a non-GAAP(1) financial measure, has been used consistently by |
|||||||||||
The following table represents |
|||||||||||
Operating Summary |
|||||||||||
Per Share |
|||||||||||
Three Months Ended |
Three Months Ended |
||||||||||
2023 |
2022 |
% Chg. |
2023 |
2022 |
% Chg. |
||||||
Insurance underwriting income(2) |
$ 3.43 |
$ 3.18 |
8 |
$ 327,825 |
$ 314,131 |
4 |
|||||
Excess investment income(2) |
0.38 |
0.31 |
23 |
35,824 |
30,716 |
17 |
|||||
Interest on debt |
(0.27) |
(0.25) |
8 |
(25,676) |
(24,658) |
4 |
|||||
Parent company expense |
(0.03) |
(0.03) |
(2,612) |
(3,067) |
|||||||
Income tax expense |
(0.68) |
(0.63) |
8 |
(64,993) |
(61,744) |
5 |
|||||
Stock compensation benefit (expense), net of tax |
(0.03) |
(0.04) |
(2,955) |
(4,057) |
|||||||
Net operating income |
2.80 |
2.55 |
10 |
267,413 |
251,321 |
6 |
|||||
Reconciling items, net of tax: |
|||||||||||
Realized gain (loss)—investments |
0.11 |
(0.08) |
10,496 |
(7,665) |
|||||||
Non-operating expenses |
(0.03) |
— |
(2,396) |
(460) |
|||||||
Legal proceedings |
(0.01) |
(0.01) |
(711) |
(853) |
|||||||
Net income(3) |
$ 2.88 |
$ 2.46 |
$ 274,802 |
$ 242,343 |
|||||||
Weighted average diluted shares outstanding |
95,464 |
98,640 |
(1) GAAP is defined as accounting principles generally accepted in |
(2) Definitions included within this document. |
(3) A GAAP-basis condensed consolidated statement of operations is included in the appendix of this report. |
Note: Tables in this earnings release may not sum due to rounding. |
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||||||||||
The following table represents |
|||||||||||
Operating Summary |
|||||||||||
Per Share |
|||||||||||
Year Ended |
Year Ended |
||||||||||
2023 |
2022 |
% Chg. |
2023 |
2022 |
% Chg. |
||||||
Insurance underwriting income |
$ 13.27 |
$ 12.32 |
8 |
$ 1,278,548 |
$ 1,219,078 |
5 |
|||||
Excess investment income |
1.35 |
1.06 |
27 |
130,382 |
104,589 |
25 |
|||||
Interest on debt |
(1.06) |
(0.91) |
16 |
(102,316) |
(90,395) |
13 |
|||||
Parent company expense |
(0.11) |
(0.11) |
(10,866) |
(11,156) |
|||||||
Income tax expense |
(2.59) |
(2.41) |
7 |
(249,546) |
(238,177) |
5 |
|||||
Stock compensation benefit (expense), net of tax |
(0.20) |
(0.23) |
(19,558) |
(22,912) |
|||||||
Net operating income |
10.65 |
9.71 |
10 |
1,026,644 |
961,027 |
7 |
|||||
Reconciling items, net of tax: |
|||||||||||
Realized gain (loss)—investments |
(0.54) |
(0.61) |
(51,884) |
(60,473) |
|||||||
Non-operating expenses |
(0.03) |
(0.04) |
(3,294) |
(4,196) |
|||||||
Legal proceedings |
(0.01) |
(0.02) |
(711) |
(1,972) |
|||||||
Net income |
$ 10.07 |
$ 9.04 |
$ 970,755 |
$ 894,386 |
|||||||
Weighted average diluted shares outstanding |
96,364 |
98,985 |
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||
MANAGEMENT VS. GAAP MEASURES |
|||
Shareholders' equity, excluding AOCI, and book value per share, excluding AOCI, are non-GAAP measures that are utilized by management to view |
|||
Year Ended |
|||
2023 |
2022 |
||
Net income |
$ 970,755 |
$ 894,386 |
|
Net operating income |
1,026,644 |
961,027 |
|
Net income as an ROE(1) |
23.2 % |
29.2 % |
|
Net operating income as an ROE (excluding AOCI)(1) |
14.7 % |
14.8 % |
|
|
|||
2023 |
2022 |
||
Shareholders' equity |
$ 4,486,803 |
$ 3,949,577 |
|
Impact of adjustment to exclude AOCI |
2,772,419 |
2,790,313 |
|
Shareholders' equity, excluding AOCI |
$ 7,259,222 |
$ 6,739,890 |
|
Book value per share |
$ 47.10 |
$ 40.05 |
|
Impact of adjustment to exclude AOCI |
29.11 |
28.30 |
|
Book value per share, excluding AOCI |
$ 76.21 |
$ 68.35 |
(1) Calculated using average shareholders' equity for the measurement period. |
INSURANCE OPERATIONS:
Life insurance accounted for 75% of the Company's insurance underwriting margin for the quarter and 70% of total premium revenue.
Health insurance accounted for 24% of the Company's insurance underwriting margin for the quarter and 30% of total premium revenue.
Net sales of life insurance increased 3% for the quarter, and net health sales increased 21%.
The following table summarizes
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited)
|
|||||
Insurance Premium Revenue |
|||||
Quarter Ended |
|||||
|
|
% Chg. |
|||
Life insurance |
$ 794,815 |
$ 762,929 |
4 |
||
Health insurance |
335,857 |
326,020 |
3 |
||
Annuity |
— |
— |
|||
Total |
$ 1,130,672 |
$ 1,088,949 |
4 |
INSURANCE UNDERWRITING INCOME |
|||||||||
Insurance underwriting margin is management's measure of profitability of the Company's life, health, and annuity segments' underwriting performance, |
|||||||||
The following table summarizes |
|||||||||
Insurance Underwriting Income |
|||||||||
Quarter Ended |
|||||||||
|
% of Premium |
|
% of Premium |
% Chg. |
|||||
Insurance underwriting margins: |
|||||||||
Life |
$ 305,480 |
38 |
$ 292,922 |
38 |
4 |
||||
Health |
97,486 |
29 |
96,224 |
30 |
1 |
||||
Annuity |
1,946 |
2,629 |
|||||||
404,912 |
391,775 |
3 |
|||||||
Other income |
123 |
384 |
|||||||
Administrative expenses |
(77,210) |
(78,028) |
(1) |
||||||
Insurance underwriting income |
$ 327,825 |
$ 314,131 |
4 |
||||||
Per share |
$ 3.43 |
$ 3.18 |
8 |
The ratio of administrative expenses to premium was 6.8%, compared with 7.2% for the year-ago quarter.
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||||||||
LIFE INSURANCE RESULTS BY DISTRIBUTION CHANNEL |
|||||||||
Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division |
|||||||||
Total premium, underwriting margins, first-year collected premium and net sales by all distribution channels are shown at |
|||||||||
Life Underwriting Margin |
|||||||||
Quarter Ended |
|||||||||
|
|||||||||
2023 |
2022 |
||||||||
Amount |
% of |
Amount |
% of |
% |
|||||
American Income |
$ 183,176 |
45 |
$ 174,755 |
46 |
5 |
||||
Direct to Consumer |
59,241 |
24 |
60,344 |
24 |
(2) |
||||
Liberty National |
31,144 |
35 |
26,768 |
32 |
16 |
||||
Other |
31,919 |
62 |
31,055 |
59 |
3 |
||||
Total |
$ 305,480 |
38 |
$ 292,922 |
38 |
4 |
Life Premium |
|||||
Quarter Ended |
|||||
|
|||||
2023 |
2022 |
% Chg. |
|||
American Income |
$ 406,356 |
$ 380,922 |
7 |
||
Direct to Consumer |
247,274 |
246,471 |
— |
||
Liberty National |
89,700 |
83,320 |
8 |
||
Other |
51,485 |
52,216 |
(1) |
||
Total |
$ 794,815 |
$ 762,929 |
4 |
||
Life |
|||||
Quarter Ended |
|||||
|
|||||
2023 |
2022 |
% Chg. |
|||
American Income |
$ 76,323 |
$ 69,796 |
9 |
||
Direct to Consumer |
25,861 |
30,676 |
(16) |
||
Liberty National |
26,046 |
23,252 |
12 |
||
Other |
2,188 |
2,568 |
(15) |
||
Total |
$ 130,418 |
$ 126,292 |
3 |
(1) |
Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, |
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||||||||
HEALTH INSURANCE RESULTS BY DISTRIBUTION CHANNEL |
|||||||||
Health Underwriting Margin |
|||||||||
Quarter Ended |
|||||||||
|
|||||||||
2023 |
2022 |
||||||||
Amount |
% of |
Amount |
% of |
% |
|||||
United American |
$ 14,180 |
10 |
$ 16,908 |
12 |
(16) |
||||
Family Heritage |
35,633 |
35 |
31,921 |
34 |
12 |
||||
Liberty National |
27,157 |
57 |
27,024 |
58 |
— |
||||
American Income |
19,080 |
62 |
18,360 |
62 |
4 |
||||
Direct to Consumer |
1,436 |
8 |
2,011 |
11 |
(29) |
||||
Total |
$ 97,486 |
29 |
$ 96,224 |
30 |
1 |
Health Premium |
|||||
Quarter Ended |
|||||
|
|||||
2023 |
2022 |
% Chg. |
|||
United American |
$ 138,586 |
$ 137,908 |
— |
||
Family Heritage |
102,180 |
94,391 |
8 |
||
Liberty National |
47,416 |
46,678 |
2 |
||
American Income |
30,676 |
29,423 |
4 |
||
Direct to Consumer |
16,999 |
17,620 |
(4) |
||
Total |
$ 335,857 |
$ 326,020 |
3 |
||
Health |
|||||
Quarter Ended |
|||||
|
|||||
2023 |
2022 |
% Chg. |
|||
United American |
$ 28,155 |
$ 20,110 |
40 |
||
Family Heritage |
25,228 |
22,432 |
12 |
||
Liberty National |
9,349 |
8,612 |
9 |
||
American Income |
4,235 |
3,921 |
8 |
||
Direct to Consumer |
2,220 |
2,188 |
1 |
||
Total |
$ 69,187 |
$ 57,263 |
21 |
(1) |
Net sales is calculated as annualized premium issued, net of cancellations in the first thirty |
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||||||
PRODUCING EXCLUSIVE AGENT COUNT RESULTS BY DISTRIBUTION CHANNEL |
|||||||
Quarterly Average Producing Agent Count(1) |
|||||||
Quarter Ended |
Quarter Ended |
||||||
|
|
||||||
2023 |
2022 |
% |
2023 |
||||
American Income |
11,131 |
9,243 |
20 |
10,983 |
|||
Liberty National |
3,387 |
2,946 |
15 |
3,339 |
|||
Family Heritage |
1,368 |
1,334 |
3 |
1,323 |
(1) |
The quarterly average producing agent count is based on the actual count at the beginning |
INVESTMENTS |
|||||
Management uses excess investment income as the measure to evaluate the performance of the investment segment. It is defined as net |
|||||
The following table summarizes |
|||||
Excess Investment Income |
|||||
Quarter Ended |
|||||
|
|||||
2023 |
2022 |
% Chg. |
|||
Net investment income |
$ 271,609 |
$ 255,483 |
6 |
||
Interest on policy liabilities(1) |
(235,785) |
(224,767) |
5 |
||
Excess investment income |
$ 35,824 |
$ 30,716 |
17 |
||
Per share |
$ 0.38 |
$ 0.31 |
23 |
(1) |
Interest on policy liabilities is a component of total policyholder benefits, a GAAP measure. The amounts presented for 2022 have |
Net investment income increased 6.3%, and average invested assets increased 3.7%. Required interest on policy liabilities increased 4.9%, and average policy liabilities increased 4.5%.
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||
The composition of the investment portfolio at book value at |
|||
Investment Portfolio |
|||
As of |
|||
|
|||
Amount |
% of Total |
||
Fixed maturities at fair value(1) |
$ 17,870,206 |
91 |
|
Mortgage loans |
279,199 |
1 |
|
Policy loans |
657,020 |
3 |
|
Other long-term investments(2) |
835,878 |
4 |
|
Short-term investments |
81,740 |
— |
|
Total |
$ 19,724,043 |
(1) |
As of |
(2) |
Includes |
Fixed maturities at amortized cost, net of allowance for credit losses, by asset class as of |
||||||
Fixed Maturity Portfolio by Sector |
||||||
As of |
||||||
|
||||||
Investment |
Below |
Total |
||||
Corporate bonds |
$ 14,574,424 |
$ 480,705 |
$ 15,055,129 |
|||
Municipals |
3,296,305 |
— |
3,296,305 |
|||
Government, agencies and GSEs |
442,903 |
— |
442,903 |
|||
Collateralized debt obligations |
— |
37,110 |
37,110 |
|||
Other asset-backed securities |
74,656 |
11,696 |
86,352 |
|||
Total |
$ 18,388,288 |
$ 529,511 |
$ 18,917,799 |
Below are fixed maturities available for sale by amortized cost, allowance for credit losses, and fair value at
As of |
Amortized Cost |
Allowance for |
Net Unrealized |
Fair Value |
|||
|
$ 18,924,914 |
$ (7,115) |
$ (1,047,593) |
$ 17,870,206 |
At amortized cost, net of allowance for credit losses, 97% of fixed maturities (97% at fair value) were rated "investment grade." The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.23% during the fourth quarter of 2023, compared with 5.18% in the year-ago quarter.
Earnings Release—Q4 2023 (Dollar amounts in thousands, except share and per share data) (Unaudited) |
|||
Comparable information for acquisitions of fixed maturity investments is as follows: |
|||
Fixed Maturity Acquisitions |
|||
Quarter Ended |
|||
|
|||
2023 |
2022 |
||
Amount |
$ 443,385 |
$ 238,845 |
|
Average annual effective yield |
6.6 % |
6.1 % |
|
Average rating |
BBB+ |
A |
|
Average life (in years) to: |
|||
Next call |
20.3 |
16.5 |
|
Maturity |
23.2 |
20.9 |
SHARE REPURCHASE:
During the quarter, the Company repurchased 660,170 shares of
For the year ended
LIQUIDITY/CAPITAL:
EARNINGS GUIDANCE FOR THE YEAR ENDING
NON-GAAP MEASURES:
In this news release,
CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
This press release may contain forward-looking statements within the meaning of the federal securities laws. These prospective statements reflect management's current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:
1) Economic and other conditions, including the continued impact of inflation, geopolitical events, and the recent pandemic on the
2) Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);
3) Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;
4) Interest rate changes that affect product sales, financing costs, and/or investment portfolio yield;
5) General economic, industry sector or individual debt issuers' financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may compromise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer's ability to make principal and/or interest payments due on those securities;
6) Changes in the competitiveness of the Company's products and pricing;
7) Litigation results;
8) Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);
9) The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;
10) The customer response to new products and marketing initiatives;
11) Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12) Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;
13) The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity and demand for our products; and
14)
Readers are also directed to consider other risks and uncertainties described in other documents on file with the
EARNINGS RELEASE CONFERENCE CALL WEBCAST:
APPENDIX |
|||||||
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||
Three Months Ended |
Year Ended |
||||||
2023 |
2022(3) |
2023 |
2022(3) |
||||
Revenue: |
|||||||
Life premium |
$ 794,815 |
$ 762,929 |
$ 3,137,244 |
$ 3,027,824 |
|||
Health premium |
335,857 |
326,020 |
1,318,773 |
1,282,417 |
|||
Other premium |
— |
— |
— |
1 |
|||
Total premium |
1,130,672 |
1,088,949 |
4,456,017 |
4,310,242 |
|||
Net investment income |
271,609 |
255,483 |
1,056,884 |
991,800 |
|||
Realized gains (losses) |
13,287 |
(9,703) |
(65,676) |
(76,548) |
|||
Other income |
123 |
384 |
308 |
1,246 |
|||
Total revenue |
1,415,691 |
1,335,113 |
5,447,533 |
5,226,740 |
|||
Benefits and expenses: |
|||||||
Life policyholder benefits(1) |
514,472 |
501,967 |
2,050,789 |
2,035,693 |
|||
Health policyholder benefits(2) |
195,686 |
191,364 |
776,362 |
752,866 |
|||
Other policyholder benefits |
9,612 |
8,947 |
37,100 |
36,875 |
|||
Total policyholder benefits |
719,770 |
702,278 |
2,864,251 |
2,825,434 |
|||
Amortization of deferred acquisition costs |
97,541 |
90,131 |
379,700 |
348,824 |
|||
Commissions, premium taxes, and non-deferred acquisition costs |
144,234 |
129,532 |
559,167 |
506,022 |
|||
Other operating expense |
91,759 |
91,804 |
347,833 |
353,954 |
|||
Interest expense |
25,676 |
24,658 |
102,316 |
90,395 |
|||
Total benefits and expenses |
1,078,980 |
1,038,403 |
4,253,267 |
4,124,629 |
|||
Income before income taxes |
336,711 |
296,710 |
1,194,266 |
1,102,111 |
|||
Income tax benefit (expense) |
(61,909) |
(54,367) |
(223,511) |
(207,725) |
|||
Net income |
$ 274,802 |
$ 242,343 |
$ 970,755 |
$ 894,386 |
|||
Basic net income per common share |
$ 2.92 |
$ 2.50 |
$ 10.21 |
$ 9.13 |
|||
Diluted net income per common share |
$ 2.88 |
$ 2.46 |
$ 10.07 |
$ 9.04 |
(1) |
Net of remeasurement gain of |
(2) |
Net of remeasurement gain of |
(3) |
The amounts presented for 2022 have been retrospectively restated due to the adoption of ASU 2018-12. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/globe-life-inc-reports-fourth-quarter-2023-results-302056597.html
SOURCE
Allstate Reports Fourth Quarter 2023 Results Profit improvement actions and mild weather benefit results – Form 8-K
First American Financial Reports Results for the Fourth Quarter and Full Year of 2023
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News